Yingying Mao

Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity

Xuejun Wang, Wei Hu, Tingyu Zhang et al. · Antiviral Research · 2015 · 61 citations

Medicine, Nephrology, Pharmacology +5

Prominence of Medullary Veins on Susceptibility-Weighted Images Provides Prognostic Information in Patients with Subacute Stroke

Xinfeng Yu, Li‐Xia Yuan, Alan Jackson et al. · American Journal of Neuroradiology · 2015 · 49 citations · Full text

Medicine, Neurology, Radiology +17

The relationship between microvasculature in white matter hyperintensities and cognitive function

Jianzhong Sun, Xinfeng Yu, Yeerfan Jiaerken et al. · Brain Imaging and Behavior · 2016 · 20 citations

Medicine, Neurology, Neuroscience +14

Blood Brain Barrier Disruption in Diabetic Stroke Related to Unfavorable Outcome

Xinfeng Yu, Xiaojun Xu, Alan Jackson et al. · Cerebrovascular Diseases · 2016 · 20 citations

Life Sciences, Neurology, Neuroscience +17

Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit

Chaohui Ye, Caiyun Miao, Yu Li et al. · Pediatrics & Neonatology · 2018 · 13 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +17